: What is illustrated by the difference between the therapeutic effect and the toxic effect (as pointed at by the blue arrow)? View
: Which were two of the things in Phase 2 trials that contribute to greater confidence in your compound View
: Which of the following was described as the easiest and most important changes that could have improved the Tegenero Phase 1 study? View
: Which three people were mentioned as those likely to get together to identify a starting dosage level? View
